June 9, 2017Headlines: "Novartis, IBM Watson Health team up for breast cancer project," Reuters "Novartis has agreed to work with IBM Watson Health to explore ways to use patient data and advanced… Read More
Headlines: "A Look at Major Drug-Pricing Proposals," The New York Times "Several bills that seek to tackle the high cost of prescription drugs are moving through Congress, and the Trump… Read More
Headlines: "Suspected Cases of Ebola Rise to 29 in Democratic Republic of Congo, The New York Times "The number of suspected cases of Ebola has risen to 29 from nine… Read More
Headlines: "The Senate Just Confirmed Scott Gottlieb to Lead the FDA," Fortune "The U.S. Senate voted on Tuesday to confirm Dr. Scott Gottlieb, a health policy expert and venture capitalist,… Read More
Headlines: "Here’s the visual proof of why vaccines do more good than harm," Science "Vaccines have beat back infectious diseases. Bubbles represent reported U.S. cases, but not all diseases were… Read More
Headlines: "The top 10 pharma R&D budgets in 2016," Fierce Biotech "Last year, biopharma won its share of new drug approvals, though not as many as we're used to in… Read More
Headlines: "FDA continues to approve most drugs faster than its European counterpart," STAT News "Amid ongoing skepticism of the US Food and Drug Administration, a new analysis finds the agency… Read More
Headlines: "In a Dragon’s Blood, Scientists Discover a Potential Antibiotic," The New York Times "Biochemists may have discovered a type of antibiotic that sounds like something out of a fairy… Read More
Headlines: "Novartis wins speedy U.S. review of new leukemia drug," Reuters "A new leukemia treatment from Novartis for children and young adults will get priority review from the U.S. Food… Read More
Headlines: "U.S. approves Roche drug that targets severe form of MS," Reuters "Roche's multiple sclerosis (MS) drug Ocrevus won U.S. approval, putting the potential blockbuster back on track after a… Read More
Our Sponsor
